Impact of HIV infection on the recurrence of tuberculosis in South India

J Infect Dis. 2010 Mar;201(5):691-703. doi: 10.1086/650528.

Abstract

Background: There is limited information on the relative proportion of reactivation and reinfection at the time of recurrence among human immunodeficiency virus (HIV)-infected and HIV-uninfected patients who are successfully treated for tuberculosis infection in India.

Methods: HIV-infected and HIV-uninfected patients with sputum culture-positive pulmonary tuberculosis were treated with short-course regimens and followed up for 36 months at the Tuberculosis Research Centre, South India. Bacteriologic recurrences were documented, and typing of strains was performed using 3 different genotypic techniques: restriction fragment length polymorphism (RFLP) by IS6110, spoligotyping, and mycobacterial interspersed repeat unit (MIRU)-variable number tandem repeat (VNTR). DNA fingerprints of paired Mycobacterium tuberculosis isolates (baseline and recurrence) were compared.

Results: Among 44 HIV-infected and 30 HIV-uninfected patients with recurrent tuberculosis during the period July 1999 to October 2005, 25 and 23 paired isolates, respectively, were typed using all 3 methods. Recurrence was due to exogenous reinfection in 88% of HIV-infected and 9% of HIV-uninfected patients (P<.05). Among recurrent isolates, the HIV-infected patients showed more clustering, as well as a higher proportion of drug resistance, including multidrug resistance.

Conclusions: In India, a tuberculosis-endemic country, most recurrences after successful treatment of tuberculosis are due to exogenous reinfection in HIV-infected persons and endogenous reactivation in HIV-uninfected persons. Strategies for prevention and treatment of tuberculosis infection must take these findings into consideration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / epidemiology*
  • Adult
  • Antitubercular Agents / therapeutic use
  • Bacterial Typing Techniques / methods
  • DNA Fingerprinting / methods
  • DNA, Bacterial / genetics
  • Female
  • Follow-Up Studies
  • Genotype
  • HIV Infections / complications*
  • Humans
  • Immunocompromised Host
  • India / epidemiology
  • Male
  • Mycobacterium tuberculosis / classification
  • Mycobacterium tuberculosis / isolation & purification
  • Recurrence
  • Tuberculosis / drug therapy
  • Tuberculosis / epidemiology*

Substances

  • Antitubercular Agents
  • DNA, Bacterial